by Kanchan Madan | Feb 25, 2022 | Press Releases
Today, the Food and Drug Administration accredited Farxiga (dapagliflozin) oral drugs to reduce the risk of kidney function decline, kidney failure, cardiovascular death, and hospitalization for heart failure in adults with continual kidney disease who are...
by Kanchan Madan | Jan 21, 2022 | Press Releases
Today, Dr. Manju Aggarwal India launched innovative kidney care, a new campaign to improve patient options for receiving dialysis. Conventional in-hospital dialysis imposes sizeable burdens on patients with kidney failure and may be both physically and emotionally...
